#1
|
|||
|
|||
1.Ñóëüôàýòèäîë. 2. Òàáëåòêè â ôîðìå ER, MR è XL-ýòî îäíî è òî æå?
Çäðàâñòâóéòå!
1.Ïåðåä òåì êàê ñïðîñèòü íà ôîðóìå, ïðèìåíÿåòñÿ ëè â Ðîññèè ñóëüôàýòèäîë, è ìîæíî ëè íà ðûíêå îáîéòèñü áåç íåãî, ÿ ïîèñêàëà â áàçàõ äàííûõ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ], [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ], up-to-date- 0 ðåçóëüòàòîâ. Îáçîð pubmed ïîçâîëÿåò ñäåëàòü âûâîäû, ÷òî ïîñëå 70-õ ãîäîâ ïðåïàðàò íå ïðèìåíÿëñÿ; ðàáîòû ïîñëåäíèõ ëåò ïîñâÿùåíû òîìó, êàê óäàëÿòü ýòè ïðåïàðàòû èç êðîâè. Ñóëüôàýòèäîë+ 0,05 ã+ áåíçîêàèí+êîíöåíòðàò îáëåïèõîâîãî ìàñëà â ôîðìå ñâå÷åé. Áåíçîêàèí, êñòàòè, ñíèæàåò àíòèáàêòåðèàëüíóþ àêòèâíîñòü ñóëüôîíàìèäîâ. 2. Ñðàâíèâàëè 2 ïðåïàðàòà òàáëåòêè êëàðèòðîìèöèíà ER extended release è XL, MR- ýòî îäíî è òî æå? (òîæå äîëãî èñêàëà, ÷òîáû íå áåñïîêîèòü âðà÷åé, íå íàøëà). Ïîìîãèòå, ïîæàëóéñòà, î÷åíü ðàññ÷èòûâàþ íà âàøó ïîìîùü.
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#2
|
||||
|
||||
Íó, íàâåðíîå, áåç ñóëüôàíèëàìèäîâ ìîæíî âîîáùå îáîéòèñü. Êðîìå áèñåïòîëà ïðè ïíåâìîöèñòíîé ïíåâìîíèè. Ïðî MR íàäî ïîäóìàòü, à îñòàëüíîå âñå îäíî è òî æå, ðåòàðäíûå ôîðìû.
|
#3
|
||||
|
||||
Êñòàòè, èçâåñòåí äîêòîð, ïîëó÷èâøèé ñðåäè êîëëåã êëè÷êó "Íîðñóëüôàçîë" çà áîëåçíåííîå ïðèñòðàñòèå ê íàçíà÷åíèþ ýòîãî ïðåïàðàòà
|
#4
|
||||
|
||||
Òîðãîâîå íàçâàíèå ñóëüôýòèäîëà - Ýòàçîë, ñòàðèííûé, åùå ñ ñîâåòñêèõ âðåìåí èçâåñòíûé ïðåïàðàò. Äî ñèõ ïîð ïðîèçâîäèòñÿ è, íàâåðíîå, êåì-òî ïîêóïàåòñÿ, õîòÿ, äåéñòâèòåëüíî, íèêàêîé íåîáõîäèìîñòè â åãî ïðèñóòñòâèè íà ðûíêå íåò,
|
#5
|
|||
|
|||
Äà, ÿ íàøëà â Ìàøêîâñêîì çà 1986 ãîä ýòàçîë. Òàêæå ÿ íå áåç óäèâëåíèÿ îáíàðóæèëà, ÷òî ñóëüôîíàìèäû íå ñïèñàíû ñî ñ÷åòîâ äàæå â ÑØÀ, è ïðèìåíÿþò äàæå â äåòñêîé ïðàêòèêå:
SULFONAMIDE ANTIBIOTICS — sulfadiazine and sulfamethoxazole which are now being used in higher than usual doses to treat toxoplasmosis in patients with AIDS. Sulfadiazine: Drug information Prevention of recurrent attacks of rheumatic fever (unlabeled use): 1 g/day USE — Treatment of urinary tract infections and nocardiosis; adjunctive treatment in toxoplasmosis; uncomplicated attack of malaria Sulfadiazine: Pediatric drug information USE — Adjunctive treatment in toxoplasmosis; treatment of urinary tract infections and nocardiosis; rheumatic fever prophylaxis in penicillin-allergic patient; uncomplicated attack of malaria Sulfisoxazole: Drug information U.S. BRAND NAMES — Gantrisin® USE — Treatment of urinary tract infections, otitis media, Chlamydia; nocardiosis Erythromycin and sulfisoxazole U.S. BRAND NAMES — Pediazole® [DSC] USE — Treatment of susceptible bacterial infections of the upper and lower respiratory tract, otitis media in children caused by susceptible strains of Haemophilus influenzae, and many other infections in patients allergic to penicillin Sulfacetamide: Patient drug information U.S. BRAND NAMES — Bleph®-10;... USE Ophthalmic: Treatment and prophylaxis of conjunctivitis due to susceptible organisms; corneal ulcers; adjunctive treatment with systemic sulfonamides for therapy of trachoma Dermatologic: Scaling dermatosis (seborrheic); bacterial infections of the skin; acne vulgaris
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#6
|
||||
|
||||
Ñóëüôàäèàçèí ñåðåáðà ïðèìåíÿåòñÿ âî ìíîãèõ ñòðàíàõ (è â Ðîññèè) êàê ìåñòíîå ñðåäñòâî äëÿ ëå÷åíèÿ îæîãîâ, ïðîëåæíåé, èíôèöèðîâàííûõ ðàí. Ñóëüôàöåòàìèä - îí æå ñóëüôàöèë-íàòðèé, àëüáóöèä - äî ñèõ ïîð øèðîêî ïðèìåíÿåòñÿ â îôòàëüìîëîãèè. Ïðîáëåìà â òîì, ÷òî áëàãîäàðÿ áåñêîíòðîëüíîìó è áåçðåöåïòóðíîìó ïîòðåáëåíèþ Áèñåïòîëà, Ýòàçîëà, Ôòàëàçîëà è ò.ä., íà ïîñòñîâåòñêîì ïðîñòðàíñòâå î÷åíü âåëèêà äîëÿ ðåçèñòåíòíûõ ê ñóëüôîíèëàìèäàì ìèêðîîðãàíèçìîâ - â îòëè÷èå îò îñòàëüíîãî ìèðà, ãäå ïîòðåáëåíèå ýòèõ ïðåïàðàòîâ áûëî âåñüìà îãðàíè÷åííûì. Ïîýòîìó â çàðóáåæíûõ ðóêîâîäñòâàõ îíè âñòðå÷àþòñÿ íåðåäêî, à âîò â îòå÷åñòâåííîé ïðàêòèêå ñåáÿ óæå ïî÷òè èçæèëè. Ïîäðîáíåå, íàïðèìåð: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|